# vTv Therapeutics (VTVT) — Earnings

VTVT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/vtvt/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.92 |
| EPS estimate | −$0.83 |
| EPS surprise | −11.52% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 12, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1641489/000164148925000053/vtvt-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 12, 2025 | −$0.83 | −$0.92 | -11.52% | — | — |
| Q1 2025 | May 15, 2025 | −$0.82 | −$0.77 | 5.52% | — | — |
| Q4 2024 | Mar 20, 2025 | −$0.87 | −$0.55 | 36.78% | — | $17,000.00 |
| Q3 2024 | Nov 12, 2024 | −$3.60 | −$0.88 | 75.56% | — | — |
| Q2 2024 | Aug 8, 2024 | −$3.20 | −$0.81 | 74.69% | — | — |
| Q1 2024 | May 9, 2024 | −$3.20 | −$1.17 | 63.44% | — | $1.0M |
| Q4 2023 | Mar 13, 2024 | −$2.80 | −$1.67 | 40.36% | — | — |
| Q3 2023 | Nov 9, 2023 | −$3.20 | −$3.20 | 0.00% | — | — |
| Q2 2023 | Aug 11, 2023 | −$2.80 | −$2.80 | 0.00% | — | — |
| Q1 2023 | May 11, 2023 | −$3.80 | −$2.40 | 36.84% | — | — |
| Q4 2022 | Mar 6, 2023 | −$2.53 | −$2.40 | 5.26% | — | $9,000.00 |
| Q3 2022 | Nov 10, 2022 | −$1.73 | −$2.00 | -15.39% | $250,000.00 | — |
| Q2 2022 | Aug 15, 2022 | −$3.60 | −$1.60 | 55.56% | — | $9,000.00 |
| Q1 2022 | May 12, 2022 | −$2.80 | −$4.00 | -42.86% | — | $2.0M |
| Q4 2021 | Mar 29, 2022 | −$2.53 | −$3.20 | -26.32% | $500,000.00 | $9,000.00 |
| Q3 2021 | Nov 9, 2021 | −$2.60 | −$0.80 | 69.23% | $1.3M | $3.0M |
| Q2 2021 | Aug 4, 2021 | −$2.80 | −$0.40 | 85.71% | $1.0M | $9,000.00 |
| Q1 2021 | May 5, 2021 | −$2.40 | −$3.20 | -33.33% | $800,000.00 | $987,000.00 |
| Q4 2020 | Feb 24, 2021 | −$2.20 | $0.80 | 136.36% | $3.3M | $6.4M |
| Q3 2020 | Nov 5, 2020 | −$4.20 | −$0.80 | 80.95% | — | $7,000.00 |

## Frequently Asked Questions

### When did vTv Therapeutics (VTVT) last report earnings?

vTv Therapeutics last reported on Aug 12, 2025, covering fiscal Q2 2025.

### Did VTVT beat earnings estimates?

No. vTv Therapeutics reported EPS of −$0.92 for Q2 2025 against a −$0.83 estimate — a 11.52% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).